INTRODUCTION: The elderly are often underrepresented in clinical trials for acute coronary syndrome (ACS), and cardiologists commonly face management dilemmas in the choice of treatment for this group of patients, particularly concerning the use of invasive revascularisation. This study analysed the characteristics of hospitalised elderly patients with ACS, and compared the outcomes of treatments. METHODS: From 29 December 2005 to 26 April 2010, 13,545 patients were admitted for ACS in 16 hospitals across Malaysia. These patients were divided into two groups - elderly (≥ 65 years) and non-elderly (< 65 years). The clinical characteristics, treatment received (invasive or non-invasive) and outcomes (in-hospital and 30-day all-cause mortality) of the two groups were compared. The elderly patients were then grouped according to the type of treatment received, and the outcomes of the two subgroups were compared. RESULTS: Elderly patients had a higher cardiovascular risk burden and a higher incidence of comorbidities. They were less likely to receive urgent revascularisation for acute ST-segment elevation myocardial infarction (elderly: 73.9% vs. non-elderly: 81.4%) and had longer door-to-needle time (elderly: 60 minutes vs. non-elderly: 50 minutes, p = 0.004). The rate of cardiac catheterisation was significantly lower in the elderly group across all ACS strata. Elderly patients had poorer outcomes than non-elderly patients, but those who received invasive treatment appeared to have better outcomes than those who received non-invasive treatment. CONCLUSION: Elderly patients with ACS tend to be undertreated, both invasively and pharmacologically. Invasive treatment seems to yield better outcomes for this group of patients.
INTRODUCTION: The elderly are often underrepresented in clinical trials for acute coronary syndrome (ACS), and cardiologists commonly face management dilemmas in the choice of treatment for this group of patients, particularly concerning the use of invasive revascularisation. This study analysed the characteristics of hospitalised elderly patients with ACS, and compared the outcomes of treatments. METHODS: From 29 December 2005 to 26 April 2010, 13,545 patients were admitted for ACS in 16 hospitals across Malaysia. These patients were divided into two groups - elderly (≥ 65 years) and non-elderly (< 65 years). The clinical characteristics, treatment received (invasive or non-invasive) and outcomes (in-hospital and 30-day all-cause mortality) of the two groups were compared. The elderly patients were then grouped according to the type of treatment received, and the outcomes of the two subgroups were compared. RESULTS: Elderly patients had a higher cardiovascular risk burden and a higher incidence of comorbidities. They were less likely to receive urgent revascularisation for acute ST-segment elevation myocardial infarction (elderly: 73.9% vs. non-elderly: 81.4%) and had longer door-to-needle time (elderly: 60 minutes vs. non-elderly: 50 minutes, p = 0.004). The rate of cardiac catheterisation was significantly lower in the elderly group across all ACS strata. Elderly patients had poorer outcomes than non-elderly patients, but those who received invasive treatment appeared to have better outcomes than those who received non-invasive treatment. CONCLUSION: Elderly patients with ACS tend to be undertreated, both invasively and pharmacologically. Invasive treatment seems to yield better outcomes for this group of patients.
Authors: Alvaro Avezum; Marcia Makdisse; Frederick Spencer; Joel M Gore; Keith A A Fox; Gilles Montalescot; Kim A Eagle; Kami White; Rajendra H Mehta; Elias Knobel; Jean-Philippe Collet Journal: Am Heart J Date: 2005-01 Impact factor: 4.749
Authors: S E Sheifer; S S Rathore; B J Gersh; K P Weinfurt; W J Oetgen; J A Breall; K A Schulman Journal: Circulation Date: 2000-10-03 Impact factor: 29.690
Authors: Rajendra H Mehta; Immad Sadiq; Robert J Goldberg; Joel M Gore; Alvaro Avezum; Frederick Spencer; Eva Kline-Rogers; Jeanna Allegrone; Karen Pieper; Keith A A Fox; Kim A Eagle Journal: Am Heart J Date: 2004-02 Impact factor: 4.749
Authors: Ilan Goldenberg; Shlomi Matetzky; Amir Halkin; Arie Roth; Elio Di Segni; Dov Freimark; Dan Elian; Oren Agranat; Yedael Har Zahav; Victor Guetta; Hanoch Hod Journal: Am Heart J Date: 2003-05 Impact factor: 4.749
Authors: Rajendra H Mehta; Vincent J Bufalino; Wenqin Pan; Adrian F Hernandez; Christopher P Cannon; Gregg C Fonarow; Eric D Peterson Journal: Am Heart J Date: 2008-03-05 Impact factor: 4.749
Authors: Padmaa Venkatason; Yong Z Zubairi; Wan Azman Wan Ahmad; Muhammad Imran Hafidz; Muhammad Dzafir Ismail; Mohd Firdaus Hadi; Ahmad Syadi Mahmood Zuhdi Journal: BMJ Open Date: 2019-05-05 Impact factor: 2.692
Authors: Padmaa Venkatason; Nur Lisa Zaharan; Muhammad Dzafir Ismail; Wan Azman Wan Ahmad; Ahmad Syadi Mahmood Zuhdi Journal: Eur J Clin Pharmacol Date: 2018-03-26 Impact factor: 2.953
Authors: Firdaus Aziz; Sorayya Malek; Khairul Shafiq Ibrahim; Raja Ezman Raja Shariff; Wan Azman Wan Ahmad; Rosli Mohd Ali; Kien Ting Liu; Gunavathy Selvaraj; Sazzli Kasim Journal: PLoS One Date: 2021-08-02 Impact factor: 3.240